ArticlePDF Available

Acute effects of caffeine intake on athletic performance: A systematic review and meta-analysis

Authors:

Abstract and Figures

Objective: Our objective was to perform a systematic review and meta-analysis of the research literature assessing the effect of caffeine on athletic performance. Methods: A total of 13 studies published between 2010 and 2015 were included in the meta-analysis of the effects of caffeine on maximum running distance (2 studies), time trial performance (7 studies), and muscle power (4 studies). The effect sizes were calculated as standardized differences in means (std in means). Meta-analysis was completed using a random effects model. Results: Caffeine supplementation did not increase maximum running distance (effect size= 0.37, p= 0.14) and muscle power (effect size= 0.17, p= 0.36). However, improvements were observed in the time trial performance (effect size= -0.40, p< 0.01). Subgroup analyses revealed that the improvement in time trial results may be related to the use of the 6 mg/kg of body weight of caffeine dose (effect size= -0.45, p= 0.01). Conclusion: Our meta-analysis showed that caffeine intake does not improve performance in maximum running distance and muscle power, but it seems to improve time trial performance. The effect of caffeine on time trial performance related to dose. Key Words: caffeine, running, exercise test, cycling, muscle power.
Content may be subject to copyright.
Rev Chil Nutr Vol. 44, Nº 3, 2017
ARTÍCULOS ORIGINALES
INTRODUCTION
Athletes are always looking for legal ergogenic aids to
increase their performance. Ergogenic aids are substances,
techniques, or sports equipment that improve sports
performance
1
. Among legal nutritional ergogenic resources,
we highlight caffeine (1,3,7-trimethylxanthine), which is one
of the most used ergogenic aids by athletes1-3. Del Coso et
al.
1
evaluated 20,686 urine samples from athletes of different
sports (i.e., handball, triathlon, cycling, rowing, athletics (track
  
and 2008. They found that 26.2% of the athletes presented
blood caffeine levels below 0.1 µg.ml-1 (limit of detection),
67.3% had below 5 µg.ml-1, and only 0.6% exceeded the
threshold of 12 µg.ml-1 (i.e., value considered as doping
      
the World Anti-Doping Agency (WADA) Prohibited List,
caffeine can be considered safe, effective, and legal when
used according to established and practiced protocols.
The prevalence of caffeine intake by athletes before
and during competition is high, with the substance obtained
from various sources, such as energy drinks, energy gels,
and tablets, carbonated sodas, and coffee
2
. In previous
studies, caffeine doses commonly range from 3 (low), 6
(moderate)5, and 10 (high)26 mg/kg of body weight when
Acute effects of caffeine intake on athletic performance:
A systematic review and meta-analysis
Efectos agudos de la ingesta de cafeína en el rendimiento
atlético: Una revisión sistemática y meta-análisis
Beatriz Gonçalves Ribeiro1,4, Anderson Pontes Morales1,2,3,4,
Felipe Sampaio-Jorge1,2,3, Felipe de Souza Tinoco1, Alessandra
Alegre de Matos1,3, Tiago Costa Leite1.
1. Laboratory of Research and Innovation in Sports Sciences, Federal
University of Rio de Janeiro UFRJ, Macaé, Brazil
2. Higher Institutes of Education of CENSA, ISECENSA,
Campos dos Goytacazes, Brazil
3. Secretary Municipal of Sport, City, Macaé, Brazil
4. Postgraduate Program in Nutrition, Institute of Nutrition, Federal
University of Rio de Janeiro UFRJ, Rio de Janeiro, Brazil.
Corresponding author. Beatriz Gonçalves Ribeiro. Laboratory of
Research and Innovation in Sports Sciences, Federal University of Rio de
Janeiro - Macaé Campus, RJ, Brazil. 159, Alcides da Conceição, Granja
dos Cavaleiros, Macaé, Rio de Janeiro, Brazil 27930-560.
Telephone: +552227933-378.
E-m ail: ribeirogoncalvesb@gmail.com
Este trabajo fue recibido el 3 de marzo de 2017


ABSTRACT
Objective: Our objective was to perform a systematic re-
view and meta-analysis of the research literature assessing
the effect of caffeine on athletic performance. Methods:
A total of 13 studies published between 2010 and 2015
were included in the meta-analysis of the effects of caffeine
on maximum running distance (2 studies), time trial per-
formance (7 studies), and muscle power (4 studies). The
effect sizes were calculated as standardized differences in
means (std in means). Meta-analysis was completed using
a random effects model. Results: Caffeine supplementation
did not increase maximum running distance (effect size=
0.37, p= 0.14) and muscle power (effect size= 0.17, p=
0.36). However, improvements were observed in the time
trial performance (effect size= -0.40, p< 0.01). Subgroup
analyses revealed that the improvement in time trial results
may be related to the use of the 6 mg/kg of body weight of
caffeine dose (effect size= -0.45, p= 0.01). Conclusion: Our
meta-analysis showed that caffeine intake does not improve
performance in maximum running distance and muscle
power, but it seems to improve time trial performance. The
effect of caffeine on time trial performance related to dose.
Key Words: caffeine, running, exercise test, cycling, muscle
power.
 

Gonçalves B., et al.
the substance is ingested 30-60 minutes before exercise
to allow the caffeine levels in the bloodstream to reach
peak values.
Caffeine may affect performance through both
peripheral and central mechanisms. The mechanism for
improved endurance, sprint, and power performance has
been related to a simple biologic mechanism, such as
glycogen sparing, increased intracellular Ca
++
concentration,
or altered excitation–contraction coupling
6-9
. However, a
caffeine paradigm for improved athletic performance is a
complex, including biologic mechanisms, and cognitive
perception5. Davis et al.10 proposed a mechanism by which
caffeine delays fatigue through its effects on the central

popularity because of previously known effects of caffeine
   
    
Although the physiological basis of caffeine intake
is well described, its clinical effect of improving athletic
performance remains controversial. Caffeine intake has
been reported to be safe to the cardiovascular system that
does not cause changes in heart rate, blood pressure and
heart rate variability11. However, the results are mixed in
the context of “strength”
12
and “resistance” tests

, using
different tests to evaluate the strength (i.e., 1-RM test and
maximal voluntary contraction - MVC) and endurance (i.e.,
repetitions until fatigue). This division does not describe the

tests into only two groups.
A pertinent question is whether the effects of caffeine
supplementation are similar in all tests considered
“endurance” or “strength” and if these effects could be

perspective, this systematic review and meta-analysis of
randomized clinical trials aims to verify whether acute
caffeine supplementation improves athletic performance
regardless of whether the tests involve “endurance” or
“strength”, but considering the same types of tests conducted
by performance athletic.


A systematic review of the literature was carried out
to analyze the acute effects of caffeine intake on athletic

running distance during the test, 2) the time trial performance
in exercise, and 3) the muscle power generated during
exercise. The search included articles published between
January 2010 and December 2015 and was carried out using
the PubMed and Bireme databases. The terms used in the
search were “caffeine” or “exercise” or “performance” or
“drink” or “capsule.” Only studies with humans were included.
Inclusion criteria

with physically active humans (i.e., individuals involved
in physical activities of medium slow/medium-intensity
physical activities); 2) studies with at least two trials (or
separate groups of subjects), in which the subjects consumed
caffeine in one trial (or group) and placebo in the other,
and 3) studies that showed results in absolute values of the
studied variables (i.e., maximum running distance, time trial
performance and muscle power).

with other known or potential ergogenic compounds (i.e.,
creatinine, ginseng, and taurine), used sweetened beverages
containing caffeine or no sugar; 2) trials that included women,
children, adolescents, and sedentary men; 3) studies that
did not have full texts (in such cases, an attempt was made
to retrieve the necessary data by e-mailing the author; and


   
a full-text analysis of all eligible articles to independently
check if all the inclusion and exclusion criteria were in
agreement. Any disagreement between reviewers was
discussed. If no agreement was reached, a third reviewer
(APM) was consulted.
Data collection

data from all eligible studies. Any disagreement was resolved
as mentioned above. Continuous outcomes, means, and
         
 
 
the data were generally extracted using means, standard
deviations, and sample sizes (n) for both caffeine and


calculated for comparison of continuous outcomes by using
a random effects model.
Assessment of bias risk and study quality
The systematic error of the 13 studies was assessed using
the Cochrane risk of bias tool. The following dimensions

concealment, blinding of participants, blinding of personnel,
blinding of outcome, incomplete outcome data, selective
outcome reporting, and other sources of bias. The risk
 
about the adequacy of the study and was expressed as “low
risk of bias,” “high risk of bias,” or “unclear risk of bias”15.
Meta-analysis
The meta-analysis was completed using the
Comprehensive Meta-analysis software (version 2.2;
Biostat Inc., Englewood, NJ). The data were extracted
and converted into a standard format by calculating the

size” in the Results and Discussion.
285
Acute effects of caffeine intake on athletic performance: a systematic review and meta-analysis


    
in the analysis. A total of 13 studies published between
2010 and 2015 were included in the meta-analysis of the
effects of caffeine on maximum running distance (n= 2),
   

individuals of the studies varied between 20.8 and 36.2
years. One study, however, did not report the age of the
subjects. The dosage of caffeine varied between ~2.5 and

the whole sample. In this case, to categorize the amount of
caffeine consumed, the quantity of consumed caffeine was
divided by the mean body mass of the sample. All articles
used caffeine in capsules. General characteristic of the
studies included on systematic review and meta-analysis
are shown in Table 1.
Analysis of the subgroup of quantitative data (Dosage)
Table 2 illustrates the effect sizes of trials related to
dosage (maximum running distance, time trial performance
and muscle power). The dosage of 6 mg/kg on the time
trial performance was significant with the effect size of
 
were identified for the effects for <6 mg/kg dosage in
the time trial performance (p= 0.18). Comparisons with
maximum running distance and muscle power were not
possible, since few articles were included for analysis
in subgroup.
Assessment of quality and publication bias
Two of the studies assessed had a clear description of
the random sequence generation (low risk of bias). Only one
study reported allocation concealment (low risk of bias). A
complete description of blinding of participants (low risk of
bias) was observed in 11 studies, and blinding of personnel
(low risk of bias) in 8 studies. One article had complete
information on blinding of outcome assessors (low risk of
bias); one article had incomplete outcomes (high risk of
bias). All 13 evaluated studies reported selective outcomes



Figure 1.
286
Gonçalves B., et al.
Table 1
General characteristic of the studies included in the systematic review and meta-analysis.
Time of
Form of Caffeine consumption Measurement Measurement Mean ± SD Mean ± SD
Reference ingestion Subjects info dosage pre-exercise (min) Test Unit Caffeine Placebo
10 male cyclists; Time Tria l
        2652 ± 270
178 ± 6 cm;
73 ± 6 kg
Maximum
        
Distance
13 male cyclists; Time Trial
        
176 ± 6 cm;
71 ± 9 kg
16 male cyclists; Time Trial
         
180.9 + 5.5 cm;
78.5 ± 6.0 kg
17 well-trained 10 Muscle
        
  
182 ± 0.06 cm;
82.2 ± 6.9 kg
12 male cyclists; Time Trial
        
  
80.2 ± 6.6 kg
12 male; Maximum
        
183 ± 7 cm; Distance
   
10 male cyclists; Muscle
        
177.5 ± 6.09 cm;
78.1±13.9 kg
   
         
  
12 male judoists; Muscle
        
1.76 ± 6.57 cm;
83.75 ± 20.2 kg
13 active males; Muscle
          
177 ± 0.06 cm;
77. 1± 7.2 k g
10 male cyclists; Time Trial
        
79.10 ± 1.65 kg
16 male cyclists; Time Trial
         
178.2 ± 8.8 cm;
  
287
Acute effects of caffeine intake on athletic performance: a systematic review and meta-analysis
Table 2

time trial performance and muscle power using a random effect model.
Time Trial
Maximum Running Distance Performance Muscle Power
Effect size Effect size
n (95% CL) p n Effect size (95% CL) p n (95% CL) p
Dosage
        
> 6 mg/kg - - - - - - 1 - -
< 6 mg/kg 1 - - 3 -0.32 (-0.80 to 0.15) 0.18 2 0.26 (-0.29 to 0.81) 0.35
Figure 2.
288
Gonçalves B., et al.
Effect of caffeine intake on maximum running distance

designed to estimate the maximum oxygen uptake - VO2max
and the maximum running distance by athletes) to assess the
maximum running distance of the subjects. The authors used
caffeine dosage of 5 mg/kg of body weight16 and 6 mg/kg of
body weight17 and found no improvement in the maximum
 

heterogeneity between the studies (I2= 0.00; p= 0.55).
Effect of caffeine intake on time trial performance


caffeine dosage of 6 mg/kg of body weight5,18 -20 , two studies
used a caffeine dosage of 3 mg/kg of body weight and

(~2.5 mg/kg of body weight)22. Desbrow et al.18 and Irwin
et al. evaluated the shortest time to reach a target amount
of work among cyclists. Bortolotti et al.5 and Acker-Hewitt
et al.
21

al.2220 and Womack et al.19 used a distance
    
performance among the subjects who ingested caffeine
 

the studies (I2= 0.00; p= 0.87).
Effect of caffeine intake on muscle power

cycling. Three of these studies23-25 used the Wingate test;
the other study26 used seven sprints for a maximum of 10
seconds. The average dosage of caffeine was 6.5 mg/kg of
body weight. The studies did not show an improvement in
the muscle power generated by the subjects who ingested

  

Figure 3.                 
Figure 4.
289
Acute effects of caffeine intake on athletic performance: a systematic review and meta-analysis

The aims of this systematic review and meta-analysis
were to evaluate the effects of caffeine supplementation
 
was that caffeine improves performance on the time trials
performance, but not on maximum running distance and
muscle power test. In addition, subgroup analysis revealed
that the effect of caffeine in the time trials performance test
may be related to 6 mg/kg of body weight dosage.
The exact mechanisms by which caffeine exerts ergogenic
effects are still under debate, with suggested mechanisms
including fatty acid mobilization and oxidation and endogenous
glycogen content sparing, attenuating fatigue27. The studies
included in the evaluation of the maximum running distance
did not improved performance with the use of caffeine (p=

response of caffeine. According to the hypothesis of Bassini
et al.
16
, the hyperammonic state changes the function of the
blood-brain barrier and is postulated to cause central fatigue
during exercise. However, we observed that the maximum
running distance was small to induce hyperammonemia in
athletes and consequently it was also small to test the positive
ergogenic effect of caffeine. Marriot et al.17 reported high
variation in maximum running distance between assessed
subjects, which they attributed to the existence of “high
and “low” responders to caffeine.

time trial results may be related to the dose. According to
Desbrow et al.
18
, the use of high caffeine dosage could
increase blood concentration of epinephrine and improve
performance during the time trials performance test.
20 explained that independent of dosage, for

occur, greater availability of muscle is required (i.e., increased
concentrations of caffeine at the site of action). Additionally,
Irwin et al. showed that acute caffeine supplementation
positively affected exercise performance. The positive
ergogenic effect of caffeine was found to be related to
alteration in the rating of perceived exertion. Desbrow et
al.18 suggested that this mechanism (i.e., the central effects
mediated by adenosine receptor antagonism) might explain
the ergogenic effect of caffeine on exercise performance
by using the time trials performance.
       
et al.
21
and Bortolotti et al.
5
may relate to the nature of the
performance protocol. Bortolotti et al.5 used closed-loop
protocol time trials. This allowed for the development of

time, preventing the athlete from reaching exhaustion.
On the other hand, although different doses of caffeine
were used, there were similarities in the methodologies
applied by Bortolotti et al.
5
, Acker-Hewitt et al.
21
, and
 
22
. In these three studies, participants ingested
caffeine 60 minutes before the test and were instructed not

hours before testing.
Regular consumption of caffeine has been associated
with an upregulation of the number of adenosine receptors
in the vascular and neural tissues of the brain
28,29
. Based on
these observations, it could be speculated that habitual and
non-habitual caffeine consumers would respond differently
to caffeine supplementation during exercise. The minimum
period of caffeine fasting in diet that is needed to obtain
greater sensitivity to its action is not well established in
30 indicated that the time
required for the beginning of abstinence varies between


in the current study, it is possible that the subjects had low
sensitivity to caffeine, which would require a longer period
of abstinence and/or an increase in the dosage used. In
22, subjects were consumers of
caffeine; thus, the dosage of 2.5 mg/kg of body weight used
may be considered low. In fact, Warren et al.31 indicated in
their meta-analysis that the commonly used caffeine dosage

These results reinforce the notion that responses to
caffeine may be triggered by other factors, such as genetics,
Figure 5.
290
Gonçalves B., et al.
rather than habitual caffeine intake per se. According to
Womack et al.19, genetic polymorphisms in genes related
to caffeine metabolism (aryl-hydrocarbon receptor [AHR],

(Decaprenyl)) are a potential explanation for the variability
in the ergogenic response to caffeine supplementation in

effect of supplementation with 6 mg/kg of body weight of
anhydrous caffeine on the performance of cyclists. Given

metabolism would be advantageous for maximizing the

     
performance of cyclists homozygous for the AA (i.e., caffeine
is metabolized at a higher rate) variant to a greater degree
compared with cyclists with the C (i.e., caffeine is metabolized
  

homozygotes compared with 1.3 minutes in the C-allele
carriers. The authors speculate that the rapid accumulation
of caffeine metabolites may have been responsible for the
positive ergogenic effect in AA homozygotes. Paraxanthin
and theophylline (metabolites downstream of caffeine

receptors than caffeine32. Thus, it is possible that a faster
caffeine metabolism in AA homozygotes created a faster
production of paraxanthine and/or theophylline and thus
increases the ergogenic effect.
It has been suggested that caffeine increases strength
and muscle power performance through greater motor unit

reticulum, and surges in nitric oxide concentrations, working
collectively to produce stronger muscle contractions
33
. H owever,
   


, which could help to explain
the limited ergogenic effect upon maximal strength and
muscle power. In their evaluation of the contractile properties
 

 
25

al.23 and Glaister et al.26
caffeine use in cyclists may be more effective in longer time
evaluations of muscle power compared to shorter tests. Thus
further research is needed to elucidate the ergogenic effects
of caffeine during muscle strength exercises.

In conclusion, this meta-analysis showed that caffeine
intake does not improve performance in maximum running
distance and muscle power, but seems to improve time
trial performance. The potential effect of caffeine on time
trial performance related to caffeine dose. The results
of the present study contribute to the knowledge of the
ergogenic effects of caffeine in several tests that evaluate
athletic performance.

   

the design, analysis or writing of this article.



B.G.R and A.A.M (Nutritionist) designed the database,
carried out the majority of the meta-analysis and contributed
to the writing and the critical review of the manuscript;
   
search and database storage and helped to design and
provided guidance for the meta-analyses used;

part of the literature search, and extraction and contributed
to the writing of the manuscript;
  
literature review and the discussion of manuscript;
T.C.L (Nutritionist) helped with the literature review and
provided a critical revision of the manuscript, especially the
discussion of results.


de la literatura de investigación que evalúa el efecto de la

estudios publicados entre 2010 y 2015 fueron incluidos en el

     

del efecto se calcularon como diferencias estandarizadas
 
completó utilizando un modelo de efectos aleatorios.




  

la mejora en los resultados de los ensayos a tiempo podía
estar relacionada con el uso de la dosis de 6 mg/kg de peso



de carrera ni la potencia muscular, pero parece mejorar el
rendimiento de la prueba de tiempo. Este efecto potencial
de la cafeína en el rendimiento de la prueba de tiempo
estuvo relacionado con la dosis.
 
ejercicio, ciclo, energía del músculo.

1. Del Coso J. Muñoz G. Muñoz-Guerra J. Prevalence of caffeine
use in elite athletes following its removal from the World
Anti-Doping Agency list of banned substances, Appl Physiol
Nutr Metab 2011; 36: 555-561.
2. Desbrow B. Leveritt M. Awareness and use of caffeine by
291
Acute effects of caffeine intake on athletic performance: a systematic review and meta-analysis
athletes competing at the 2005 Ironman Triathlon World
Championships, Int J Sport Nutr Exerc Metab 2006; 16:
545-558.
3. Desbrow B. Leveritt M. Well-trained endurance athletes’
knowledge, insight, and experience of caffeine use, Int J
Sports Nutr Exerc Metab 2007; 17: 328-339.
4. Irwin C. Desbrow B. Ellis A. Rant BO. Leveritt M. Caffeine
withdrawal and high-intensity endurance cycling performance,
J Sports Sci 2011; 29: 509-515.
5. Bortolotti H. Altimari LR. Vitor-Costa M. Cyrino ES. Performance
during a 20-km cycling time-trial after caffeine ingestion, J
Int Soc Sports Nutr 2014; 11: 1-7.
6. Clausen T. Na+-K+ pump regulation and skeletal muscle
contractility, Physiol Rev 2003; 83: 1269-1324.
7. Doherty M. Smith P. Hughes M. Davison R. Caffeine lowers
perceptual response and increases power output during high
intensity cycling. J Sports Sci 2004; 22: 637-643.
8. Roy BD. Bosman MJ. Tarnopolsky MA. An acute oral dose
of caffeine does not alter glucose kinetics during prolonged
dynamic exercise in trained endurance athletes, Eur J Appl
Physiol 2001; 85: 280- 286.
9. Van Soeren MH. Sathasivam P. Spriet LL. Graham TE. Caffeine
metabolism and epinephrine responses during exercise in
users and nonusers, J Appl Physiol 1993; 75: 805-812.
10. Davis JM. Zhao Z. Stock HS. Mehl KA. Buggy J. Hand GA.
Central nervous system effects of caffeine and adenosine on
fatigue, Am J Physiol Regul Integr Comp Physiol 2003; 284:
399-404.
11. An SM. Park JS. Kim SH. Effect of energy drink dose on exercise
capacity, heart rate recovery and heart rate variability after
high-intensity exercise, J Exerc Nutrition Biochem 2014; 18:
31-39.
12. Goldstein E. Jacobs PL. Whitehurst M. Penhollow T. Antonio J.
Caffeine enhances upper body strength in resistance-trained
women, J Int Soc Sports Nutr 2010; 14: 7-18.
13. Jacobs I. Pasternak H. Bell DG. Effects of ephedrine, caffeine,
and their combination on muscular endurance, Med Sci
Sports Exerc 2003; 35: 987-994.
14. Williams AD. Cribb PJ. Cooke MB. Hayes A. The effect of
ephedra and caffeine on maximal strength and power in
resistance trained athletes, J Strength Cond Res 2008; 22:
464-470.
15. Higgins JP. Altman DG. Gøtzsche PC. Jüni P. Moher D. Oxman
AD. Savovic J. Schulz KF. Weeks L. Sterne JA. Cochrane Bias
Methods Group. Cochrane Statistical Methods Group. The
Cochrane Collaboration’s tool for assessing risk of bias in
randomised trials, BMJ 2011; 343: d5928.
16. Bassini A. Magalhães-neto AM. Sweet E. Bottino A. Veiga C.
Marta B. Tozzi MB. Pickard MB. Cameron L. Caffeine decreases
systemic urea in elite soccer players during intermittent
exercise, Med Sci Sports Exerc 2013; 45: 683-690.
17. Marriott M. Krustrup P. Mohr M. Ergogenic effects of caffeine
and sodium bicarbonate supplementation on intermittent
exercise performance preceded by intense arm cranking
exercise, J Int Soc Sports Nutr 2015; 12: 1-8.
18. Desbrow B. Biddulph C. Devlin B. Grant GD. Anoopkumar-
Dukie S. Leveritt MD. The effects of different doses of caffeine
on endurance cycling time trial Performance, J Sports Sci
2011; 30: 115-120.
19. Womack CJ. Saunders MJ. Bechtel MK. Bolton DJ. Martin
M. Luden ND. Dunham W. Hancock M. The inuence of a
CYP1A2 polymorphism on the ergogenic effects of caffeine,
J Int Soc Sports Nutr 2012; 9: 1-7.
20. Skinner TL. Jenkins DG. Taaffe DR. Leveritt MD. Coombesa
JS. Coinciding exercise with peak serum caffeine does not
improve cycling performance, J Sci Med Sport 2013; 16:
54-59.
21. Acker-Hewitt TL. Shafer BM. Saunders MJ. Goh Q. Luden
ND. Independent and combined effects of carbohydrate
and caffeine ingestion on aerobic cycling performance in
the fed state, Appl Physiol Nutr Metab 2012; 37: 276-283.
22. Spence AL. Sim M. Landers G. Peeling P. A comparison
of caffeine versus pseudoephedrine on cycling Time-Trial
performance, Int J Sports Nutr Exerc Metab 2013; 23: 507-
512.
23. Silva CG. Cavazzotto TG. Queiroga MR. Supplementation
of caffeine and anaerobic power indicators, Rev Educ Fís
2014; 25: 109-116.
24. Souissi M. Abedelmalek S. Chtourou H. Atheymen R. Hakim
A. Sahnoun Z. Effects of morning caffeine ingestion on
mood states, simple reaction time, and short-term maximal
performance on elite judoists, Asian J Sports Med 2012; 3:
161-168.
25. Souissi M. Chtourou H. Abedelmalek S. Ghozlane IB. Sahnoun
Z. The effects of caffeine ingestion on the reaction time
and short-term maximal performance after 36 h of sleep
deprivation, Physiol Behav 2014; 131: 1-6.
26. Glaister M. Patterson SD. Foley P. Pedlar CR. Pattison JR.
McInnes G. Caffeine and sprinting performance: dose responses
and efcacy, J Strength Cond Res 2012; 26: 1001-1005.
27. Magkos F. Kavouras SA. Caffeine use in sports, pharmacokinetics
in man, and cellular mechanisms of action, Crit Rev Food
Sci Nutr 2005; 45: 535-562.
28. Fredholm BB. Adenosine actions and adenosine receptors
after 1 week treatment with caffeine, Acta Physiol Scand
1982; 115: 283-286.
29. Fredholm BB. Battig K. Holmen J. Nehlig A. Zvartau EE.
Actions of caffeine in the brain with special reference to
factors that contribute to its widespread use, Pharmacological
reviews 1999; 51: 83-133.
30. Tavares C. Sakata RK. Caffeine in the treatment of pain, Rev
Bras Anestesiol 2012; 62: 387-401.
31. Warren GL. Park ND. Maresca RD. McKibans KI. Millard-
Stafford ML. Effect of caffeine ingestion on muscular strength
and endurance: a meta-analysis, Med Sci Sports Exerc 2010;
42: 1375-13 87.
32. Daly JW. Butts-Lamb P. Padgett W. Subclasses of adenosine
receptors in the central nervous system: interaction with
caffeine and related methylxanthines, Cell Mol Neurobiol
1983; 3: 69-80.
33. Kalmar JM. The inuence of caffeine on voluntary muscle
activation, Med Sci Sports Exerc 2005; 37: 2113-2119.
34. Mitsumoto H. DeBoer GE. Bunge G. Andrish JT. Tetzlaff JE.
Cruse RP. Fiber-type specic caffeine sensitivities in normal
human skinned muscle bers, Anesthesiol 1990; 72: 50-54.
35. Pagala MK. Taylor SR. Imaging caffeine-induced Ca2+ transients
in individual fast-twitch and slow-twitch rat skeletal muscle
bers, Am J Physiol 1998; 274: C623-632.
... In terms of the ergogenic effect of caffeine, previous studies have generally indicated a performance-enhancing effect [43,44], although contradictory results have been reported in some cases [44,45]. This inter-individual variation in response to caffeine consumption may stem from genetic variations in genes responsible for caffeine metabolism or sensitivity, such as CYP1A2 and ADORA2A [29,44]. ...
... In terms of the ergogenic effect of caffeine, previous studies have generally indicated a performance-enhancing effect [43,44], although contradictory results have been reported in some cases [44,45]. This inter-individual variation in response to caffeine consumption may stem from genetic variations in genes responsible for caffeine metabolism or sensitivity, such as CYP1A2 and ADORA2A [29,44]. ...
... In terms of the ergogenic effect of caffeine, previous studies have generally indicated a performance-enhancing effect [43,44], although contradictory results have been reported in some cases [44,45]. This inter-individual variation in response to caffeine consumption may stem from genetic variations in genes responsible for caffeine metabolism or sensitivity, such as CYP1A2 and ADORA2A [29,44]. Previous research has revealed that the ADORA2A genotype may influence the effect of caffeine on sports performance improvement. ...
Article
Full-text available
Previous studies have reported that TT genotype carriers of the adenosine A2a receptor (ADORA2A) gene rs5751876 polymorphism have better ergogenic and anti-inflammatory responses to caffeine intake compared to C allele carriers. The aim of the present study was twofold: (1) to investigate the association of the ADORA2A rs5751876 polymorphism with acute caffeine supplementation on hormonal (growth hormone and testosterone) response to resistance exercise (RE); (2) to examine the relationship between the rs5751876 polymorphism and the resting levels of growth hormone and testosterone in athletes who are light caffeine consumers. A double-blind, crossover, placebo-controlled study involving 30 resistance-trained men (age 21.7 ± 4.1) was conducted to assess the impact of caffeine supplementation on serum growth hormone (GH) and testosterone (TS) levels before, immediately after, and 15 min post-RE. One hour before engaging in resistance exercise, subjects were randomly administered 6 mg of caffeine per kg of body mass or a placebo (maltodextrin). After a 7-day washout period, the same protocol was repeated. Resting testosterone and growth hormone levels were examined in the sera of 94 elite athletes (31 females, age 21.4 ± 2.8; 63 males, age 22.9 ± 3.8). Caffeine consumption led to significantly greater increases in GH and TS in men with the TT genotype compared to C allele carriers. Furthermore, in the group of athletes, carriers of the TT genotype had significantly higher testosterone (p = 0.0125) and growth hormone (p = 0.0365) levels compared to C allele carriers. In conclusion, the ADORA2A gene rs5751876 polymorphism may modify the effect of caffeine intake on the hormonal response to exercise.
... However, Buck et al. [103] did not observe significant effects in 6 × 20 m repeated-sprint ability with the same dose of CAF among female team ball players. Furthermore, RPE scores were unaffected by CAF supplementation, consistent with meta-analyses [17,104] showing minimal improvements in jumping, sprinting, agility, and endurance in team sports with moderate CAF doses (3-6 mg·kg −1 ), and no change in perceived exertion. A recent meta-analysis on women's team sports [16] further supports this, suggesting that short recovery periods between sprints may not allow CAF to counteract fatigue. ...
Article
Listening to self-selected motivational music (SSMM) during warm-ups and caffeine (CAF) intake prior to exercise can independently enhance athletic performance among female athletes. Likewise, the potential synergistic effects of these interventions have not yet been thoroughly examined. Objective: The purpose of the study was to assess the independent and combined effects of SSMM during warm-up and pre-exercise CAF intake on maximal short-duration performance in female athletes. Methods: Seventeen female handball players (aged 16.7 ± 0.4 years) participated in a randomized, double-blind, crossover study. Each athlete completed four conditions: (i) placebo (PLA) with no interventions, (ii) music and placebo (MUS), (iii) caffeine intake only (CAF), and (iv) a combination of music and caffeine (MUS + CAF). Performance assessments included the countermovement jump (CMJ), modified agility t-test (MAT), repeated-sprint ability (RSA) test (mean and peak sprint performance), and rating of perceived exertion (RPE). Results: The MUS (p > 0.05; p < 0.01; p < 0.01; p < 0.001, respectively), CAF (all p < 0.001), and MUS + CAF (all p < 0.01) conditions significantly outperformed the PLA condition in CMJ, MAT, RSA mean, and RSA peak measures. No significant differences were observed between the CAF and MUS + CAF conditions; however, the best performances were recorded during MUS + CAF. RPE scores remained consistent across conditions. Conclusions: Warm-up routines incorporating either SSMM or a moderate dose of CAF (6 mg·kg−1) enhance anaerobic performance in female athletes. While both interventions are effective independently, CAF intake elicits a stronger effect. Although no significant difference was demonstrated for this combination, the concurrent use of SSMM and CAF appears to produce a potential effect, emerging as the most effective strategy for optimizing anaerobic performance.
... Consistently, our narrative review also identified exercise performance as the most heavily studied topic, with endurance sports, such as cycling and long-distance running, being the primary focus. Over the past decades, the relationship between caffeine and exercise performance has been widely documented [30,31,[74][75][76]. However, as Naulleau, et al. [23] noted, when exercise is restricted to hot environments, the body of research becomes much smaller. ...
Article
Full-text available
Background: Caffeine is widely recognized as an ergogenic aid to enhance athletic performance, yet its effects in hot environments remain relatively underexplored. Aims: To provide a comprehensive overview of the research landscape and identify research themes in this field. Methods: We systematically searched the Web of Science (WoS) and SCOPUS databases using keywords related to caffeine (e.g., caffe*), hot environments (e.g., heat, hot, or therm*), and athletic performance (e.g., cardio, endurance, or strength). The Bibliometrix package in R was used for bibliometric analysis and result visualization, while a narrative review was subsequently performed to identify research themes. Results: We found that studies examining the impact of caffeine on exercise in hot conditions are relatively sparse and have progressed slowly in recent years. Research in this domain has predominantly been concentrated within an academic network led by Professor Lawrence Armstrong. Recent contributions have been sporadically made by emerging scholars, with collaborations largely confined to a few research groups and countries. Key research themes identified include exercise performance, thermoregulation, fluid balance, physiological responses, immune responses, synergistic effects with other compounds, and the influence of individual differences. Of these, the first three themes—exercise performance, thermoregulation, and fluid balance—have received the most attention. Conclusions: Caffeine’s effects on exercise performance in hot environments have not been thoroughly studied. The existing research themes are varied, and the conclusions show considerable inconsistencies. Our study highlights the need for further research into the effects of caffeine dosage, administration methods, and population-specific variables. We also call for increased collaboration among research groups to advance scientific understanding and address the gaps in this field.
... Intriguingly, the effects of CAF ingestion on sprint performance are inconsistent. For example, a meta-analysis by Gonçalves Ribeiro et al. (2017) found no significant effects of CAF on maximal power output, whereas Grgic (2018) meta-analysis reported improvements in both mean and peak power during the Wingate sprint test after CAF. Similarly, studies on the effects of CAF on muscle force show mixed results. ...
Article
Full-text available
This study investigated the effect of caffeinated chewing gum (GUMCAF) on muscle fatigue (isometric vs. dynamic) after severe-intensity cycling bouts. Fifteen trained male cyclists participated in four visits. Each visit involved two severe-intensity cycling bouts (Δ1 and Δ2) lasting 6 min, separated by a 5-min recovery period. Muscle fatigue was assessed by isometric maximal voluntary knee extension contraction (IMVC) with twitch interpolation technique and dynamically by 7 s all-out cycling sprints. Assessments were performed before GUMCAF (Pre-GUM) and after the cycling bouts (Post-Exercise). GUMCAF and placebo gum (GUMPLA) were administered in a randomized double-blind procedure with participants receiving each gum type (GUMCAF and GUMPLA) during two separate visits. The results showed no significant interaction between gum types and time for the isometric and dynamic measurements (p > 0.05). The percentage change in performance from Pre-GUM to Post-Exercise showed no significant difference between GUMCAF and GUMPLA for either the dynamic-derived TMAX (~ −17.8% and −15.1%, respectively; p = 0.551) or isometric IMVC (~ −12.3% and −17.7%, respectively; p = 0.091) measurements. Moderate to large correlations (r = 0.31–0.51) were found between changes in sprint maximal torque and maximal power output measurements and isometric force, for both gum conditions. GUMCAF was not effective in attenuating muscle force decline triggered by severe-intensity cycling exercises, as measured by both isometric and dynamic methods. The correlations between IMVC and cycling maximal torque and power output suggest caution when interpreting isometric force as a direct measure of fatigue during dynamic cycling exercises.
... In individuals with athletic training, muscle fatigue manifests as the incapacity to continuously produce muscle strength or power for a determined duration [33]. Under these circumstances, CAF has been recognized as a legitimate ergogenic aid, proven to effectively boost performance across a spectrum of sports, notably those predominantly dependent on muscular power [34] and endurance [7]. ...
Article
Full-text available
Objectives The objective of this systematic review and meta-analysis is to evaluate the influence of caffeine (CAF) intake strategies, taking into account their form, timing, and dosage, on heart rate variability (HRV) indices in the post-exercise recovery period. Methods: The meta-analysis adhered to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines and is registered in the PROSPERO database (CRD42023425885). A comprehensive literature search was carried out across MEDLINE, Web of Science, LILACS, and SCOPUS, concluding in May 2023. We concentrated on randomized clinical trials comparing CAF supplementation effects to placebo on HRV indices post-exercise in active adults aged 18 and above. The primary endpoint was the assessment of HRV indices, measured both prior to and following exercise. Results Of the 10 studies included, 7 were used for the meta-analysis, and all contributed to the systematic review. The research explored a variety of CAF strategies, spanning different forms (capsule, drink, gum), times (10, 45, 60 min) and doses (2.1 to 6.0 mg/kg). The outcomes revealed no substantial variations between the placebo and CAF conditions in terms of both the square root of the average of successive squared differences between adjacent RR intervals (RMSSD) (standardized mean difference (SMD) -0.03, 95% CI -0.265 to 0.197, p=0.77) and high frequency (HF) index (SMD -0.061, 95% CI -0.272 to 0.150, p=0.57). Furthermore, metaregression analysis, employing a fixed-effects model and accounting for the administered CAF doses, revealed no significant correlation between caffeine doses and HRV indices (p>0.05). Conclusion In conclusion, there is moderate-certainty evidence suggesting that different CAF intake strategies, encompassing aspects such as form, time, and dose, do not have a significant impact on HRV indices recovery post-exercise (i.e., vagal modulation).
... Additionally, these scores were not influenced by CAF supplementation irrespective of the three varying doses of CAF ingested. This finding aligns with those of meta-analyses [17,78] showing minimal improvements in performance aspects such as jumping, sprinting, agility, and team-sport-specific endurance with moderate CAF consumption (3-6 mg·kg −1 ), with no change in perceived exertion during physical exercise. These results are further supported by a recent meta-analysis on women's team sports [15]. ...
Article
Full-text available
Caffeine (CAF) is among the most extensively researched dietary supplements worldwide. However, little is known about the relationship between dosage and performance enhancement, particularly in female athletes. This study aimed to explore the effects of three different CAF dosages (3 mg·kg−1, 6 mg·kg−1, and 9 mg·kg−1) on high-intensity exercise and the prevalence of undesirable side effects related to these doses among female team-sports athletes. All participants (n = 16; age: 16.9 ± 0.6 y; height: 1.64 ± 0.1 m; BMI: 21.6 ± 1.5 kg·m−2) were mild CAF consumers. This study had a randomized, crossover, double-blind design in which each athlete performed four experimental sessions after ingesting either a placebo (PLAC), 3 mg·kg−1 CAF (CAF-3), 6 mg·kg−1 CAF (CAF-6), or 9 mg·kg−1 of CAF (CAF-9), with an in-between washout period of at least 72 h. In each experimental session, 60 min after ingesting the capsules, participants underwent a countermovement jumps test (CMJ), modified agility t-test (MATT), repeated sprint ability (RSA) test, and a rating of perceived exertion (RPE) and completed the CAF side effects questionnaire. Our findings revealed that in comparison to the PLAC condition, the MATT, RSAmean, and RSAbest performances were significantly greater only under the CAF-6 and CAF-9 conditions. Although the RPE scores remained unchanged, CMJ performance improved under all CAF conditions. All the performance outcomes were better for the CAF-6 and CAF-9 conditions than for the CAF-3 condition. Notably, no significant difference between the CAF-6 and CAF-9 conditions was observed for any of these parameters despite the highest incidence of side effects being noted for the CAF-9 condition. In summary, our findings highlight the recommendation for a moderate CAF dosage of 6 mg·kg−1 rather than 3 or 9 mg·kg−1 to enhance various aspects of short-term maximal performance in mild-CAF-consumer female team-sports athletes while mitigating the occurrence of adverse CAF side effects.
... Bunlar, farklı egzersiz türlerinde aerobik dayanıklılık performansı ve tek tekrarlı maksimum kuvvet, izokinetik zirve torku, dikey sıçrama yüksekliği, kas dayanıklılığı gibi parametrelerin kafein ile ilişkisini incelemiştir. Bu analizlerin sonucunda kafein alınmasının dayanıklılığı artırdığı, sıçrama yüksekliği, izokinetik zirve torku ve maksimum kuvvet değerlerinde iyileşmelere sebep olduğu tespit edilmiştir 39,40,41 . Kafein, çeşitli fiziksel performans parametreleri üzerindeki önemli etkilerinin yanı sıra, özellikle uykudan yoksun kişilerde, tüketildiğinde akut bilişsel faydalar da sağlamaktadır. ...
Article
Full-text available
Rationale How caffeine (CAF) intake and warm-up music combination affect male taekwondo athletes’ performance during simulated combat is yet unstudied. Objective This study examined the potential synergistic effects of low dose of CAF and warm-up music on subsequent taekwondo combat outcomes. Methods In a double-blinded, randomized, crossover study, 16 male taekwondo athletes performed simulated combats under six conditions: (a) control, (b) CAF without music (CAF + NM), (c) placebo without music (PL + NM), (d) CAF with music (CAF + M), (e) PL with music (PL + M), and (f) no supplement with music (NS + M). After warming-up, athletes rated their felt arousal (FAS). Perceived exertion (RPE), feeling scale (FS), FAS, and physical enjoyment (PACES) were determined after combat while mean (HRmean) and peak (HRpeak) heart rate were determined for each bout. Each combat was analyzed to determine time-motion aspects and technical-tactical skills. Results CAF + M shortened skip and pause times than CAF and music in single-use (p < 0.05), while extend attack time than other conditions (p < 0.001). Additionally, CAF + M increased attacks and defensive actions above that of single treatment conditions (all p < 0.05). Moreover, CAF + M improved FS and FAS post-combat than the other conditions (p < 0.001) and PACES compared to NS + M, PL + NM and PL + M conditions (p < 0.05). Similarly, CAF + M reduced HRmean and HRpeak than the other conditions (p < 0.05). Conclusion Combining low dose of CAF and warm-up music could be an effective strategy to enhance taekwondo combat performance in male athletes.
Article
Full-text available
Amaç: Bu araştırmada Kafein kullanımımın performansı arttırdığı çalışmalarda gösterilmiştir ancak kullanılan kafein kahve şeklindedir. Bu bağlamda bu çalışmanın amacı elit futbolcularda kafein kullanımının çeviklik ve dayanıklılık performansına olan etkisinin değerlendirilmesidir. Gereç ve Yöntem: Bu araştırmada Aydın Yıldızspor Futbol Kulübünün 10 kişiden oluşan lisanslı sporcu grubuna, Kafeinin akut etkisini ölçmek amaçlı 9 haftalık bir test uygulanmıştır. Sporculara hiçbir içecek tüketmeden, kafeinli kahve ve kafeinsiz kahve tükettikten sonraki çeviklik (T-test) ve dayanıklılık performansları (Yo-Yo Aralıklı Toparlanma Testi) ölçülmüştür. Bulgular: Çalışma sonuçlarına göre direkt, kafeinli ve kafeinsiz çeviklik ölçümleri sonucunda küresellik varsayımı yoktur (p>0,05) ve istatiksel açıdan 3 farklı ölçüm arasında istatiksel açıdan anlamlı farklılık çıkmıştır (p0,05) ve istatiksel açıdan 3 farklı ölçüm arasında istatiksel açıdan anlamlı farklılık çıkmıştır (p
Article
Full-text available
Caffeine and sodium bicarbonate ingestion have been suggested to improve high-intensity intermittent exercise, but it is unclear if these ergogenic substances affect performance under provoked metabolic acidification. To study the effects of caffeine and sodium bicarbonate on intense intermittent exercise performance and metabolic markers under exercise-induced acidification, intense arm-cranking exercise was performed prior to intense intermittent running after intake of placebo, caffeine and sodium bicarbonate. Male team-sports athletes (n = 12) ingested sodium bicarbonate (NaHCO3; 0.4 g.kg(-1) b.w.), caffeine (CAF; 6 mg.kg(-1) b.w.) or placebo (PLA) on three different occasions. Thereafter, participants engaged in intense arm exercise prior to the Yo-Yo intermittent recovery test level-2 (Yo-Yo IR2). Heart rate, blood lactate and glucose as well as rating of perceived exertion (RPE) were determined during the protocol. CAF and NaHCO3 elicited a 14 and 23% improvement (P < 0.05), respectively, in Yo-Yo IR2 performance, post arm exercise compared to PLA. The NaHCO3 trial displayed higher [blood lactate] (P < 0.05) compared to CAF and PLA (10.5 ± 1.9 vs. 8.8 ± 1.7 and 7.7 ± 2.0 mmol.L(-1), respectively) after the Yo-Yo IR2. At exhaustion CAF demonstrated higher (P < 0.05) [blood glucose] compared to PLA and NaHCO3 (5.5 ± 0.7 vs. 4.2 ± 0.9 vs. 4.1 ± 0.9 mmol.L(-1), respectively). RPE was lower (P < 0.05) during the Yo-Yo IR2 test in the NaHCO3 trial in comparison to CAF and PLA, while no difference in heart rate was observed between trials. Caffeine and sodium bicarbonate administration improved Yo-Yo IR2 performance and lowered perceived exertion after intense arm cranking exercise, with greater overall effects of sodium bicarbonate intake.
Article
Full-text available
The aim was to investigate the effect of caffeine on anaerobic power intermittently trained cyclists. Ten athletes underwent two experimental sessions in a model randomized double-blind study. In each session, subjects ingested a random capsule caffeine (6 mg / kg) or placebo. One hour after, two tests Wingate were carried (T1, T2) for determining the anaerobic performance with 4 min of rest between each exercise bout. Statistical analysis used ANOVA for repeated measures revealed no significant differences between the caffeine and placebo trials. In comparing intra-tests was significantly reduced only to Mean Power (W) between sessions with caffeine (T1c: 673.6 ± 59.5 vs. T2c: 589.0 ± 58.8). The acute oral intake of caffeine did not contribute to the increase in intermittent anaerobic performance, however, the reduction in average power with the use of caffeine, may suggest a preference for fatty acid metabolism, which would be disadvantageous during intermittent maximal efforts.
Article
Full-text available
The purpose of this research was to investigate the effects of exercise capacity, heart rate recovery and heart rate variability after high-intensity exercise on caffeine concentration of energy drink. The volunteers for this study were 15 male university student. 15 subjects were taken basic physical examinations such as height, weight and BMI before the experiment. Primary tests were examined of VO2max per weight of each subjects by graded exercise test using Bruce protocol. Each of five subject was divided 3 groups (CON, ECGⅠ, ECGⅡ) by matched method based on weight and VO2max per weight what gained of primary test for minimize the differences of exercise capacity and ingestion of each groups. For the secondary tests, the groups of subjects were taken their materials before and after exercise as a blind test. After the ingestion, subjects were experimented on exercise test of VO2max 80% by treadmill until the all-out. Heart rate was measured by 1minute interval, and respiratory variables were analyzed VO2, VE, VT, RR and so on by automatic respiratory analyzer. And exercise exhaustion time was determined by stopwatch. Moreover, HRV was measured after exercise and recovery 3 min. Among the intake groups, ECGⅡ was showed the longest of exercise exhaustion time more than CON group (p = .05). Result of heart rate during exercise according to intake groups, there was significant differences of each time (p < .001), however, not significant differences of each groups and group verse time (p > .05). Result of RPE during exercise according to intake groups, there was significant differences of each time (p < .001), however, not significant differences of each groups and group verse time (p > .05). In conclusion, EDGⅡ showed the significant increase of exercise exhaustion time more than CON group (p=.05) and not significant differences in HR, RPE, RER, HRV, HRR, blood pressure (p > .05). Therefore, 2.5 mg/kg(-1) ingestion of energy drink might be positive effect to increase exercise performance capacity without side-effect in cardiovascular disease.
Article
Full-text available
Both caffeine (CAF) and pseudoephedrine (PSE) are proposed to be central nervous system stimulants. However, during competition, CAF is a permitted substance, whereas PSE is a banned substance at urinary levels >150 μg.L-1. As a result, this study aimed to compare the effect of CAF versus PSE use on cycling time trial (TT) performance to explore whether the legal stimulant was any less ergogenic that the banned substance. Here, 10 well-trained male cyclists and/or triathletes were recruited for participation. All athletes were required to attend the laboratory on four separate occasions, inclusive of a familiarisation trial and three experimental trials which required participants to complete a simulated 40 km (1200 kJ) cycling TT, after the ingestion of either 200 mg CAF, 180 mg PSE or a non-nutritive placebo (PLA). The results showed that the total time taken and the mean power produced during each TT was not significantly different (p>0.05) between trials, despite a 1.3% faster overall time (~57 sec) after CAF consumption. Interestingly, the time taken to complete the second 50% of the TT was significantly faster (p<0.05) in CAF as compared to PSE (by 99 sec), with magnitude based inferences suggesting a 91% beneficial effect of CAF during the second half of the TT. This investigation further confirms the ergogenic benefits of CAF use during TT performances, and further suggests this legal CNS stimulant has a better influence than a supra-therapeutic dose of PSE.
Article
Full-text available
The purpose of the present study was to evaluate the ergogenic effect of caffeine ingestion on mood state, simple reaction time, and muscle power during the Wingate test recorded in the morning on elite Judoists. TWELVE ELITE JUDOISTS (AGE: 21.08 ± 1.16 years, body mass: 83.75 ± 20.2 kg, height: 1.76 ±6.57 m) participated in this study. Mood states, simple reaction time, and muscle power during the Wingate test were measured during two test sessions at 07:00 h and after placebo or caffeine ingestion (i.e. 5 mg/kg). Plasma concentrations of caffeine were measured before (T0) and 1-h after caffeine' ingestion (T1) and after the Wingate test (T3). Our results revealed an increase of the anxiety and the vigor (P<0.01), a reduction of the simple reaction time (P<0.001) and an improvement of the peak and mean powers during the Wingate test. However, the fatigue index during this test was unaffected by the caffeine ingestion. In addition, plasma concentration of caffeine was significantly higher at T1 in comparison with T0. In conclusion, the results of this study suggest that morning caffeine ingestion has ergogenic properties with the potential to benefit performance, increase anxiety and vigor, and decrease the simple reaction time.
Article
Purpose: We investigated the effects of caffeine on the ammonia and amino acid metabolism of elite soccer players. Methods: In this double-blind randomized study, athletes (n = 19) received 5 mg·kg caffeine or lactose (LEx, control) and performed 45 min of intermittent exercise followed by an intermittent recovery test (Yo-Yo IR2) until exhaustion. The caffeine-supplemented athletes were divided into two groups (CEx and SCEx) depending on their serum caffeine levels (<900% and >10,000%, respectively). Data were analyzed by ANOVA and Tukey post hoc test (P < 0.05 was considered to be statistically significant). Results: Caffeine supplementation did not significantly affect the performance (LEx = 12.3 ± 0.3 km·h, 1449 ± 378 m; CEx = 12.2 ± 0.5 km·h, 1540 ± 630 m; SCEx = 12.3 ± 0.5 km·h, 1367 ± 330 m). Exercise changed the blood concentrations of several amino acids and increased the serum concentrations of ammonia, glucose, lactate, and insulin. The LEx group showed an exercise-induced increase in valine (∼29%), which was inhibited by caffeine. Higher serum caffeine levels abolished the exercise-induced increase (∼24%-27%) in glutamine but did not affect the exercise-induced increase in alanine (∼110%-160%) and glutamate (42%-61%). In response to exercise, the SCEx subjects did not exhibit an increase in uremia and showed a significantly lower increase in their serum arginine (15%), citrulline (16%), and ornithine (ND) concentrations. Conclusions: Our data suggest that caffeine might decrease systemic urea by decreasing the glutamine serum concentration, which decreases the transportation of ammonia to the liver and thus urea synthesis.
Article
Background The objective of this study was to analyze the effect of caffeine ingestion on the performance and physiological variables associated with fatigue in 20-km cycling time trials. Methods In a double-blind placebo-controlled crossover study, 13 male cyclists (26 ± 10 y, 71 ± 9 kg, 176 ± 6 cm) were randomized into 2 groups and received caffeine (CAF) capsules (6 mg.kg−1) or placebo (PLA) 60 min before performing 20-km time trials. Distance, speed, power, rpm, rating of perceived exertion (RPE), electromyography (EMG) of the quadriceps muscles and heart rate (HR) were continuously measured during the tests. In addition, BRUMS questionnaire was applied before and after the tests. Results Significant interactions were found in power and speed (P = 0.001), which were significantly higher at the end of the test (final 2 km) after CAF condition. A main effect of time (P = 0.001) was observed for RPE and HR, which increased linearly until the end of exercise in both conditions. The time taken to complete the test was similar in both conditions (PLA = 2191 ± 158 s vs. CAF = 2181 ± 194 s, P = 0.61). No significant differences between CAF and PLA conditions were identified for speed, power, rpm, RPE, EMG, HR, and BRUMS (P > 0.05). Conclusion The results suggest that caffeine intake 60 min before 20-km time trials has no effect on the performance or physiological responses of cyclists.
Article
The aim of the present study was to investigate the effects of caffeine ingestion on cognitive and physical performances after 36 h of sleep deprivation. In randomized order, thirteen healthy male physical education students (age: 21.1 ± 1.1 years, body mass: 77.1 ± 7.2 kg, height: 1.77 ± 0.06 m) completed four test sessions at 18:00 h: after placebo or 5 mg·kg− 1 of caffeine ingestion during a baseline night (RN) (bed time: from 22:30 h to 07:00 h) or a night of 36 h of sleep deprivation (TSD). During each test session, participants performed the squat jump (SJ), the reaction time, and the 30-s Wingate tests (i.e., for the measurement of the peak (PP) and mean (MP) powers and the fatigue index (FI)). The results showed that PP and MP decreased and FI increased during the TSD compared to RN in the placebo condition (p < 0.001). The caffeine ingestion improved PP after TSD compared to RN (p < 0.001). SJ decreased significantly after the TSD compared to RN after both placebo and caffeine ingestions (p < 0.001). However, SJ increased significantly after caffeine ingestion during RN and TSD (p < 0.001). The reaction time increased significantly after TSD compared to RN (p < 0.001). However, the reaction time decreased significantly after the caffeine ingestion only during the TSD (p < 0.001). Therefore, caffeine is an effective strategy to counteract the effect of 36 h of sleep loss on physical and cognitive performances.
Article
Objectives: To investigate whether coinciding peak serum caffeine concentration with the onset of exercise enhances subsequent endurance performance. Design: Randomised, double-blind, crossover. Methods: In this randomised, placebo-controlled, double-blind crossover study, 14 male trained cyclists and triathletes (age 31±5year, body mass 75.4±5.7 kg, VO₂max 69.5±6.1 mL kg⁻¹ min⁻¹ and peak power output 417±35W, mean±SD) consumed 6 mg kg(-1) caffeine or a placebo either 1h (C(1h)) prior to completing a 40 km time trial or when the start of exercise coincided with individual peak serum caffeine concentrations (C(peak)). C(peak) was determined from a separate 'caffeine profiling' session that involved monitoring caffeine concentrations in the blood every 30 min over a 4h period. Results: Following caffeine ingestion, peak serum caffeine occurred 120 min in 12 participants and 150 min in 2 participants. Time to complete the 40 km time trial was significantly faster (2.0%; p=0.002) in C(1h) compared to placebo. No statistically significant improvement in performance was noted in the C(peak) trial versus placebo (1.1%; p=0.240). Whilst no differences in metabolic markers were found between C(peak) and placebo conditions, plasma concentrations of glucose (p=0.005), norepinephrine and epinephrine (p≤0.002) were higher in the C(1h) trial 6 min post-exercise versus placebo. Conclusions: In contrast to coinciding peak serum caffeine concentration with exercise onset, caffeine consumed 60 min prior to exercise resulted in significant improvements in 40 km time trial performance. The ergogenic effect of caffeine was not found to be related to peak caffeine concentration in the blood at the onset of endurance exercise.